NCT04692467View on ClinicalTrials.gov

Treatment of Early Hypertension Among Persons Living With HIV in Haiti

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

December 30, 2023

Conditions
HIV/AIDSPre Hypertension
Interventions
DRUG

Amlodipine 5mg

Amlodipine, Haiti's first-line antihypertensive medication, will be administered to the intervention group.

Trial Locations (1)

Unknown

GHESKIO, Port-au-Prince

All Listed Sponsors
collaborator

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic

OTHER

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT04692467 - Treatment of Early Hypertension Among Persons Living With HIV in Haiti | Biotech Hunter | Biotech Hunter